Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin for Spastic Equinovarus Foot in Post-Stroke Patients
NCT03405948Completed
- Sponsor
- Assistance Publique-Hôpitaux de Marseille
- Start
- May 2006
- Primary completion
- May 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial in spastic equinovarus foot (SEVF) comparing Botulinum Toxin with Placebo (2 arms). Primary endpoint: Posture at 6 weeks. Started May 2006; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
spastic equinovarus foot (SEVF)
Beyond the preview
Go deeper on NCT03405948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03405948.